Clinical Trial Update: Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma that progressed after Osimertinib; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis
• Lung Adenocarcinoma

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Leptomeningeal Metastasis | Phase 2 | Status: RECRUITING